Page 1 E N G LIS H D E U T S C H ITA LIA N O F R A N Ç A IS E S P ...

More documents

Recommendations

Info

�� Manufactured by Hergestellt von Fabriqué par Fabbricato da Fabricado por Fabricado por Tillverkare Fremstillet a Κατασκευαστής �� Consult Instructions for Use Gebrauchsanweisung beachten Consultare le istruzioni per l’uso Consulter la notice d’emploi Consulte las instrucciones de uso Consulte as instruções de utilização Benyt brugsanvisninger Läs bruksanvisningen Συμβουλευθείτε τις οδηγίες χρήσης For In Vitro Diagnostic Use In Vitro Diagnosticum Usage In Vitro Per Uso Diagnostico In Vitro Para Uso Diagnóstico In Vitro Utilizar Apenas Em Diagnóstico In Vitro För in-vitro diagnostiskt bruk Til in Vitro diagnosticering In vitro διαγνωστική ιατρική συσκευή � �� Authorized Representative Bevollmächtigter Représentant agréé Rappresentante autorizzato Representante autorizado Representante autorizado Auktoriserad representant Autoriseret repræsentan Εξουσιοδοτημένος αντιπρόσωπος στην Ευρωπαϊκή Κοινότητα Temperature Limit Temperaturlimit Limite de température Limite di temperatura Límite de temperatura Limite de temperatura Temperaturgränser Temperaturgrænse Όριο θερμοκρασίας ��
Page 1 and 2:
��
Page 3 and 4:
q Coated Strips Part 4660 12 each P
Page 5 and 6:
Representative Standard Curve Stand
Page 7 and 8:
Accuracy Comparative studies were p
Page 9 and 10:
8 Proportion of Population (%) ≤
Page 11 and 12:
10 HRT Study - Linear Regression of
Page 13 and 14:
MITGELIEFERTE REAGENZIEN UND MATERI
Page 15 and 16:
Hinzugeben der Stopplösung und Abl
Page 17 and 18:
Störsubstanzen Die folgenden Subst
Page 19 and 20:
18 Anteil an der Population (%) Ver
Page 21 and 22:
Prognose der skelettalen Reaktion:
Page 23 and 24:
REAGENTI E MATERIALI FORNITI 96 sag
Page 25 and 26:
Arresto/Lettura 11. Aggiungere a ci
Page 27 and 28:
Sostanze interferenti Le seguenti s
Page 29 and 30:
28 Proporzione della popolazione (%
Page 31 and 32:
Previsione della risposta scheletri
Page 33 and 34:
RÉACTIFS ET MATÉRIAUX FOURNIS 96
Page 35 and 36:
Arrêt/Lecture 11. Ajouter 100 µL
Page 37 and 38:
phosphatase alcaline osseuse En cou
Page 39 and 40:
38 Proportion de la population (%)
Page 41 and 42:
Prédiction de la réaction osseuse
Page 43 and 44: REACTIVOS Y MATERIALES PROPORCIONAD
Page 45 and 46: Parada/lectura 11. Añada 100 µL d
Page 47 and 48: Sustancias que interfieren Se anali
Page 49 and 50: 48 Proporción de población (%) Di
Page 51 and 52: Previsión de la respuesta esquelé
Page 53 and 54: REAGENTES E MATERIAIS FORNECIDOS 96
Page 55 and 56: Parar/Ler 11. Adicionar 100 µL de
Page 57 and 58: Substâncias interferentes As subst
Page 59 and 60: 58 Proporção da População (%) D
Page 61 and 62: 60 Percentagem de alteração na LS
Page 63 and 64: LEVEREDE MATERIALER OG REAGENSER 96
Page 65 and 66: 13. Kvantificeringssoftware med en
Page 67 and 68: Lægemiddelinterferenser Diverse ko
Page 69 and 70: Overvågning af behandlingen: En ve
Page 71 and 72: 70 LSBMD procentændring til 12 mdr
Page 73 and 74: MEDFÖLJANDE REAGENSER OCH MATERIAL
Page 75 and 76: KVALITETSKONTROLL Analyscertifikate
Page 77 and 78: Läkemedelsinterferens Olika koncen
Page 79 and 80: Användning av Metra-BAP för över
Page 81 and 82: 80 LSBMD % förändring till 12 må
Page 83 and 84: ΠΑΡΕΧΟΜΕΝΑ ΑΝΤΙΔΡΑ
Page 85 and 86: Επώαση υποστρώματο
Page 87 and 88: Ακρίβεια Η ακρίβει
Page 89 and 90: 88 30,0% 25,0% 20,0% 15,0% 10,0% 5,
Page 91 and 92: 90 30,0% 25,0% 20,0% 15,0% 10,0% Κ
Page 93: REFERENCES LITERATURVERWEISE BIBLIO
show all

Page 1 E N G LIS H D E U T S C H ITA LIA N O F R A N Ç A IS E S P ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?